Goodwill and Intangible Assets (Tables)
|
12 Months Ended |
Dec. 31, 2021 |
| Goodwill and Intangible Assets Disclosure [Abstract] |
|
| Summary of changes in the carrying amount of goodwill |
The following table summarizes the changes in the carrying amount of goodwill: | | | | | | | (in millions) | | | Balance as of December 31, 2019 | $ | 15,604 | | Additions(a) | 17,008 | | | Foreign currency translation adjustments | 512 | | | Balance as of December 31, 2020 | 33,124 | | Additions(b) | 177 | | Measurement period adjustments(c) | (564) | | | Foreign currency translation adjustments and other | (358) | | | Balance as of December 31, 2021 | $ | 32,379 | |
(a)Goodwill additions related to the acquisition of Allergan in the second quarter of 2020 and the acquisition of Luminera in the fourth quarter of 2020 (see Note 5). (b)Goodwill additions related to the acquisition of Soliton in the fourth quarter of 2021 (see Note 5). (c)Measurement period adjustments recorded in 2021 related to the acquisition of Allergan (see Note 5).
|
| Schedule of definite-lived intangible assets |
The following table summarizes intangible assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2021 | | 2020 | | as of December 31 (in millions) | Gross carrying amount | | Accumulated amortization | | Net carrying amount | | Gross carrying amount | | Accumulated amortization | | Net carrying amount | | Definite-lived intangible assets | | | | | | | | | | | | | Developed product rights | $ | 88,945 | | | $ | (18,463) | | | $ | 70,482 | | | $ | 87,707 | | | $ | (11,620) | | | $ | 76,087 | | | License agreements | 8,487 | | | (3,688) | | | 4,799 | | | 7,828 | | | (2,916) | | | 4,912 | | | Total definite-lived intangible assets | 97,432 | | | (22,151) | | | 75,281 | | | 95,535 | | | (14,536) | | | 80,999 | | | Indefinite-lived research and development | 670 | | | — | | | 670 | | | 1,877 | | | — | | | 1,877 | | | Total intangible assets, net | $ | 98,102 | | | $ | (22,151) | | | $ | 75,951 | | | $ | 97,412 | | | $ | (14,536) | | | $ | 82,876 | |
|
| Schedule of indefinite-lived intangible assets |
The following table summarizes intangible assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2021 | | 2020 | | as of December 31 (in millions) | Gross carrying amount | | Accumulated amortization | | Net carrying amount | | Gross carrying amount | | Accumulated amortization | | Net carrying amount | | Definite-lived intangible assets | | | | | | | | | | | | | Developed product rights | $ | 88,945 | | | $ | (18,463) | | | $ | 70,482 | | | $ | 87,707 | | | $ | (11,620) | | | $ | 76,087 | | | License agreements | 8,487 | | | (3,688) | | | 4,799 | | | 7,828 | | | (2,916) | | | 4,912 | | | Total definite-lived intangible assets | 97,432 | | | (22,151) | | | 75,281 | | | 95,535 | | | (14,536) | | | 80,999 | | | Indefinite-lived research and development | 670 | | | — | | | 670 | | | 1,877 | | | — | | | 1,877 | | | Total intangible assets, net | $ | 98,102 | | | $ | (22,151) | | | $ | 75,951 | | | $ | 97,412 | | | $ | (14,536) | | | $ | 82,876 | |
|
| Schedule of anticipated annual amortization expense |
The anticipated annual amortization expense for definite-lived intangible assets recorded as of December 31, 2021 is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in billions) | 2022 | | 2023 | | 2024 | | 2025 | | 2026 | | Anticipated annual amortization expense | $ | 7.2 | | | $ | 7.5 | | | $ | 8.0 | | | $ | 8.4 | | | $ | 7.9 | |
|